Artisan Partners Portfolio holdings
AUM
$61.3B
1-Year Est. Return
26.25%
This Fund
S&P 500
1 Year Est. Return
+26.25%
AUM
$61.3B
AUM Growth
-$4.07B
(-6.2%)
Holding
365
Top Buys
| 1 | +$659M | |
| 2 | +$515M | |
| 3 | +$355M | |
| 4 |
Edwards Lifesciences
EW
|
+$333M |
| 5 |
IQVIA
IQV
|
+$329M |
Top Sells
| 1 | +$860M | |
| 2 | +$653M | |
| 3 | +$439M | |
| 4 |
Netflix
NFLX
|
+$365M |
| 5 |
Danaher
DHR
|
+$317M |
Sector Composition
| 1 | Financials | 26.49% |
| 2 | Healthcare | 18.86% |
| 3 | Technology | 17.27% |
| 4 | Industrials | 10.97% |
| 5 | Communication Services | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Cellebrite
CLBT
$3.67B
| $30.1M | 0.05% |
2,185,797
+750,909
|
|
||
252
Public Storage
PSA
$53.3B
| $29.9M | 0.05% |
110,277
-7,953
|
|
||
253
Procept Biorobotics
PRCT
$1.5B
| $29.7M | 0.05% |
1,187,349
-333,351
|
|
||
254
Acadia Pharmaceuticals
ACAD
$3.71B
| $29.6M | 0.05% |
+1,331,813
|
|
||
|
RAL
255
Ralliant Corp
RAL
$6.93B
| $28.9M | 0.05% |
694,284
-48,018
|
|
||
256
Kaspi.kz JSC
KSPI
$17.2B
| $28.6M | 0.05% |
386,095
+33,101
|
|
||
257
Raymond James Financial
RJF
$27.9B
| $28.3M | 0.05% |
+195,666
|
|
||
258
Warby Parker
WRBY
$3.01B
| $28.3M | 0.05% |
1,342,003
+243,589
|
|
||
259
Paychex
PAYX
$34.7B
| $27.6M | 0.05% |
+299,664
|
|
||
260
Revvity
RVTY
$11.7B
| $27.4M | 0.04% |
312,370
-21,598
|
|
||
|
BWIN
261
Baldwin Insurance Group
BWIN
$1.89B
| $26.7M | 0.04% |
+1,217,970
|
|
||
262
Kodiak Sciences
KOD
$2.3B
| $26.3M | 0.04% |
690,322
-146,184
|
|
||
263
Calix
CALX
$2.54B
| $26M | 0.04% |
529,875
-60,312
|
|
||
264
Mercury Systems
MRCY
$6.71B
| $25.8M | 0.04% |
+354,265
|
|
||
|
PVLA
265
Palvella Therapeutics
PVLA
$1.7B
| $24.2M | 0.04% |
193,796
-17,757
|
|
||
|
CRCL
266
Circle Internet Group
CRCL
$28.1B
| $23.9M | 0.04% |
+250,076
|
|
||
267
Palantir
PLTR
$375B
| $22.8M | 0.04% |
+156,084
|
|
||
268
HealthEquity
HQY
$7.38B
| $22.6M | 0.04% |
270,942
-271,274
|
|
||
|
SAIL
269
SailPoint Inc
SAIL
$10.7B
| $22.6M | 0.04% |
1,706,651
-33,473
|
|
||
270
Repligen
RGEN
$6.99B
| $22.4M | 0.04% |
190,100
-3,597
|
|
||
271
Tarsus Pharmaceuticals
TARS
$2.56B
| $21.6M | 0.04% |
307,307
-129,269
|
|
||
|
KRMN
272
Karman Holdings
KRMN
$7.62B
| $21.4M | 0.03% |
+267,574
|
|
||
273
Denali Therapeutics
DNLI
$3.34B
| $21.1M | 0.03% |
+1,099,719
|
|
||
274
Novanta
NOVT
$5.67B
| $20.8M | 0.03% |
175,967
+45,348
|
|
||
275
Edgewise Therapeutics
EWTX
$3.68B
| $20.8M | 0.03% |
659,067
-45,010
|
|